Published in World J Nephrol on December 06, 2012
Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia. Front Genet (2015) 0.82
IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine. Case Rep Nephrol (2014) 0.79
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med (2000) 4.99
Successful treatment of class V+IV lupus nephritis with multitarget therapy. J Am Soc Nephrol (2008) 1.98
Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry (2005) 1.67
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int (2005) 1.18
Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology (Oxford) (2005) 1.12
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol (2006) 1.09
Treatment of lupus nephritis in children. Pediatr Nephrol (2000) 1.07
Mizoribine: mode of action and effects in clinical use. Pediatr Int (2002) 1.01
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. Rheumatology (Oxford) (2008) 0.99
Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Clin Nephrol (2005) 0.95
A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus (2007) 0.92
Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials. Lupus (2011) 0.91
Lupus nephritis in children--a review of 167 patients. Pediatrics (1994) 0.91
Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases. Nephrol Dial Transplant (2010) 0.90
Cyclosporine (CsA) in lupus nephritis: assessing the evidence. Nephrol Dial Transplant (2008) 0.88
Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr (2000) 0.87
Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis. Lupus (2010) 0.87
Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis. J Rheumatol (2010) 0.87
Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Lupus (2007) 0.87
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study. Lupus (2010) 0.86
Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center. Nephron Clin Pract (2009) 0.86
Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis. Lupus (2010) 0.85
Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Clin Nephrol (2009) 0.85
FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3. Kidney Int (2002) 0.84
Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome. Pediatr Nephrol (2011) 0.84
Protective effects of Mizoribine on Cyclosporine A nephropathy in rats. Pediatr Res (2009) 0.84
Mizoribine for the treatment of lupus nephritis in children and adolescents. Clin Nephrol (2004) 0.84
Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models. Microsurgery (2003) 0.83
Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis. Clin Rheumatol (2010) 0.82
Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease. Clin Exp Nephrol (2011) 0.82
Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group. Nephron Clin Pract (2008) 0.82
Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus. Rheumatol Int (2010) 0.81
Treatment for lupus nephritis: a revisit. Nephrology (Carlton) (2005) 0.81
Good response of membranous lupus nephritis to tacrolimus. Clin Nephrol (2006) 0.81
Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Lupus (2009) 0.81
New treatment strategies for proliferative lupus nephritis: keep children in mind! Lupus (2007) 0.80
Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Lupus (2006) 0.79
Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis. Clin Nephrol (2011) 0.78
Long-term multidrug therapy in an adolescent patient with proliferative lupus nephritis: a trial of less cytotoxic therapy. Clin Nephrol (2012) 0.77
Treatment of lupus nephritis with cyclosporine - an outcome analysis. Kidney Blood Press Res (2007) 0.77
Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis. Lupus (2010) 0.77
Efficacy of cyclosporine therapy for systemic lupus erythematosus in childhood. Pediatr Int (2008) 0.76
Clinical success of Neoral absorption profile. Transplant Proc (2004) 0.76
Tacrolimus monotherapy in a patient with lupus flare using once-daily administration protocol. NDT Plus (2011) 0.76
Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy. Tohoku J Exp Med (2006) 0.76
Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare. Rheumatol Int (2011) 0.76
Treatment of steroid-resistant systemic lupus erythematosus with extremely low dose of cyclosporine A. Pediatr Int (2004) 0.76
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 26.12
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol (2005) 9.17
EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J (2006) 2.51
Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem (2008) 1.78
Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol (2007) 1.75
Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect (2006) 1.22
The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology (2009) 1.19
Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res (2011) 1.16
Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol (2002) 1.16
Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells (2008) 1.14
Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol (2006) 1.12
IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Am J Nephrol (2010) 1.01
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur J Cancer (2011) 1.00
Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse. Oral Oncol (2005) 0.99
Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells. Biochem Cell Biol (2004) 0.98
Phylogenetic analysis of rotaviruses with predominant G3 and emerging G9 genotypes from adults and children in Wuhan, China. J Med Virol (2009) 0.96
PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem (2009) 0.96
Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice. Nephron Clin Pract (2013) 0.95
Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci Res (2007) 0.93
Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis (2009) 0.92
Expression of IP-10/CXCL10 is upregulated by double-stranded RNA in BEAS-2B bronchial epithelial cells. Respiration (2006) 0.91
Retinoic acid-inducible gene-I is constitutively expressed and involved in IFN-gamma-stimulated CXCL9-11 production in intestinal epithelial cells. Immunol Lett (2009) 0.88
Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells. Neurosci Res (2012) 0.87
Proteasome inhibitor MG-132 enhances the expression of interleukin-6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinase. Immunol Cell Biol (2002) 0.87
Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. Pathol Int (2002) 0.86
Cytokine modulation of retinoic acid-inducible gene-I (RIG-I) expression in human epidermal keratinocytes. J Dermatol Sci (2006) 0.86
Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells. Nephrol Dial Transplant (2010) 0.85
Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells. Immunol Cell Biol (2004) 0.85
Expression of retinoic acid-inducible gene-I in lupus nephritis. Nephrol Dial Transplant (2007) 0.85
Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. Neurosci Res (2007) 0.85
The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha. J Immunol (2009) 0.85
Antiviral signaling through retinoic acid-inducible gene-I-like receptors. Arch Immunol Ther Exp (Warsz) (2011) 0.85
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol (2015) 0.85
Phylogenetic analysis of rotaviruses with genotypes G1, G2, G9 and G12 in Bangladesh: evidence for a close relationship between rotaviruses from children and adults. Arch Virol (2008) 0.84
Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome. Pediatr Nephrol (2011) 0.84
Melanoma differentiation-associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases. Tohoku J Exp Med (2012) 0.84
Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer's disease amyloid, in human cerebral blood vessels. Neurosci Lett (2002) 0.84
Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection. Pediatr Res (2012) 0.84
Effect of hypoxia on the expression of fractalkine in human endothelial cells. Tohoku J Exp Med (2003) 0.83
Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways. J Virol (2012) 0.83
Upregulation of vascular endothelial growth factor by heat-killed Listeria monocytogenes in macrophages. Biochem Biophys Res Commun (2007) 0.82
Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis. Clin Rheumatol (2010) 0.82
Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group. Nephron Clin Pract (2008) 0.82
Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis. Clin Exp Nephrol (2014) 0.81
Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology (Carlton) (2013) 0.81
Interferon-alpha2b induces p21cip1/waf1 degradation and cell proliferation in HeLa cells. Cell Cycle (2010) 0.81
Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. Brain Res (2002) 0.81
Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol Cell Endocrinol (2006) 0.81
Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes. Neuroreport (2003) 0.81
Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int (2004) 0.81
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization. J Pathol (2015) 0.80
MDA5 and ISG56 mediate CXCL10 expression induced by toll-like receptor 4 activation in U373MG human astrocytoma cells. Neurosci Res (2013) 0.80
Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma. Oral Oncol (2007) 0.80
Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation. Neurosci Res (2009) 0.80
Foreign RNA induces the degradation of mitochondrial antiviral signaling protein (MAVS): the role of intracellular antiviral factors. PLoS One (2012) 0.80
Inflammatory chemokine expression via Toll-like receptor 3 signaling in normal human mesangial cells. Clin Dev Immunol (2013) 0.79
Polyinosinic-polycytidylic acid induces the expression of interferon-stimulated gene 20 in mesangial cells. Nephron Exp Nephrol (2011) 0.79
Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis. Pediatr Nephrol (2007) 0.79
Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. Brain Res Mol Brain Res (2005) 0.79
Phosphorylation of serine 349 of p62 in Alzheimer's disease brain. Acta Neuropathol Commun (2014) 0.79
Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells. Inflammation (2004) 0.79
TLR4 signaling induces retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 in mesangial cells. J Nephrol (2013) 0.78
Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis. Tohoku J Exp Med (2013) 0.78
Imbalance towards Th1 pathway predominance in purpura nephritis with proteinuria. Pediatr Nephrol (2011) 0.78
Interaction between interferon-stimulated gene 56 and melanoma differentiation-associated gene 5 in Toll-like receptor 3 signaling in normal human mesangial cells. Am J Nephrol (2013) 0.78
Hypoxia enhances the expression of plasminogen activator inhibitor-1 in human lung cancer cells, EBC-1. Tohoku J Exp Med (2002) 0.78
Effect of MG132, a proteasome inhibitor, on the expression of growth related oncogene protein-alpha in human umbilical vein endothelial cells. Cytokine (2003) 0.78
Podocytes: recent biomolecular developments. Biomol Concepts (2014) 0.78
Characterization of retinoic acid-inducible gene-I (RIG-I) expression corresponding to viral infection and UVB in human keratinocytes. J Dermatol Sci (2012) 0.78
Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation. Neurosci Res (2011) 0.78
Interleukin-1 induces the expression of vascular endothelial growth factor in human pericardial mesothelial cells. Heart Vessels (2007) 0.77
A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent. Rheumatol Int (2012) 0.77
Polyinosinic-polycytidylic acid induces the expression of GRO-alpha in BEAS-2B cells. Inflammation (2005) 0.77
Novel role for molecular transporter importin 9 in posttranscriptional regulation of IFN-ε expression. J Immunol (2013) 0.77
Long-term multidrug therapy in an adolescent patient with proliferative lupus nephritis: a trial of less cytotoxic therapy. Clin Nephrol (2012) 0.77
Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates CXCL11 expression in HeLa cells. Life Sci (2008) 0.77
Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome. Tohoku J Exp Med (2010) 0.77
Expression of melanoma differentiation associated gene 5 is increased in human gastric mucosa infected with Helicobacter pylori. J Clin Pathol (2012) 0.77